During cholinergic transmission at
G 4 AChE has been found in mammalian tissues, including brain, muscle and heart (2); its expression pattern exhibits a close resemblance to PRiMA RNA expression (6) . In addition to the key role of AChE in cholinergic function, the correct orientation of AChE catalytic subunits at the cell surfaces of certain neurons, targeted by PRiMA, is proposed to be required for neurite outgrowth (7) . Additionally, G 4 AChE in the brain is related with amyloid plaques and neurofibrillary tangles in Alzheimer's disease and may contribute to its development (8) .
Thus, G 4 AChE may have distinct functions in different tissues.
Although G 4 is not the major form of AChE in muscle, its existence is tightly controlled. Several studies have revealed that the level of G 4 AChE is controlled by the dynamic activity of skeletal muscles. In mammals, fast-twitch muscles contain a high amount of G 4 , whereas slow-twitch muscles contain a much smaller amount (9) . Alteration of the G 4 AChE level after muscle denervation strongly suggests a critical role of motor nerves in G 4 AChE regulation (2, 10) . The motor nerves may achieve this regulation by two distinct mechanisms: release of trophic factor and nerve-evoked electrical activity.
Among the known nerve-derived trophic factors, calcitonin gene-related peptide (CGRP), a neuropeptide with 37 amino acids, which has been identified in spinal cord motor neurons (11) , exerts an innervation-like effect to suppress G 4 AChE when applied in muscles (12) . In addition, CGRP regulates the synthesis of the AChE T subunit (13) (14) (15) and of acetylcholine receptors (AChR) (11) . On the other hand, exercise induces a marked change in the level of this enzyme form, without modification of other molecular species (16) (17) (18) . Unfortunately, G 4 AChE was analyzed only by sedimentation, and the expression of PRiMA, the only G 4 -specific component, has not been studied under physiological conditions.
In this study, we sought to identify well as AChE T 
Experimental Procedures
Cell cultures -The mouse C2C12 muscle cell line was obtained from the American Type Culture Collection (ATCC, Manassas, VA).
Undifferentiated C2C12 myoblasts were maintained in Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 20% fetal bovine serum (FBS) and incubated at 37 o C in a water-saturated 5% CO 2 incubator. All reagents for cell cultures were from Invitrogen (Carlsbad, CA). Myogenic differentiation was induced as previously described (19) . In brief, the cultured myoblasts were allowed to grow in DMEM with 10% FBS until they were confluent, and then they were changed to DMEM with 2% heat-inactivated horse serum to induce differentiation. In the myogenesis studies, cell lysates were collected on each day starting from the first day of induction (day 0)
to the eighth day (day 7), and the extracts were The mouse myogenin and myoD cDNAs were described in Lee et al. (20) . 
RESULTS

Regulation of G 4 AChE and PRiMA during myogenic differentiation
Cultured mouse C2C12 cells were used as a model system for determining the expression profile of AChE during myogenic differentiation. In the absence of serum, C2C12 myoblasts were allowed to undergo fusion, forming multi-nucleated myotubes.
The western blots showed that AChE T protein (~68 kDa) increased by ~8. (as well as on day 7) of myotube formation;
however, the increase in G 1 was more robust (over 100-fold) ( 6A ). Expression of AChE T mRNA was also reduced to ~50% in the drug-treated samples, as reported previously (19) . In parallel with the muscular activity-and CGRP-induced PRiMA down regulation, the amount of G 4
AChE in cultured myotubes was selectively decreased by these treatments: the reduction of G 4 AChE was over 40% (Fig. 6B and C) . In contrast, the expression of the total A 12 AChE remained almost unchanged.
CREB phosphorylation mediates PRiMA suppression
The phosphorylation of CREB is one CaMKII is one of the downstream effectors of the muscular activity-inducing agents (22, 30) and therefore could be responsible for the CREB phosphorylation. In cultured myotubes, application of activity-inducing agents (ACh and A23187) induced a sustained phosphorylation of CaMKII (~50 kDa) that was at least 5-fold stronger ( Fig. 7A and B) .
The total amount of CaMKII remained unchanged at different time intervals.
Additionally, the activity-induced CREB phosphorylation could be fully blocked by the pre-treatment with KN62, a CaMKII inhibitor, in cultured myotubes (Fig. 7C) . To confirm the role of CaMKII in phosphorylating CREB, we over expressed an active form of CaMKII in cultured myotubes; this over expression induced an activation of CREB (Fig. 7D ).
These results, therefore, suggest that CREB may act as one of the downstream effectors for CaMKII activation in muscle.
In cultured myotubes, over expression of CREB decreased AChE T and PRiMA mRNAs in a dose-dependent manner; the reduction was more significant for PRiMA mRNA ( fold in tibialis, one day after the denervation.
The levels of AChE T mRNA decreased in both types of muscles, starting from one day after denervation, which served as a control ( In contrast, the soleus contained higher levels (over 5-fold higher) of active forms of CREB than the tibialis (Fig. 9C) . One day after denervation, both muscles showed a reduction of CaMKII and CREB phosphorylation by at least 40% as compared to the sham-operated control muscles ( Fig. 9C and D) ; this reduction appeared early in soleus, and it was sustained until eight days after the denervation. 
